To better define the contribution of tumor-specific p38α activity to systemic p38i effects in the immune TME, the p38α isoform (encoded by Mapk14) was inactivated in 4T1 cells using the CRISPR/Cas9 approach (Suppl. Here, MAPK14 is linked to neoplasm.